Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01514383 · ClinicalTrials.gov registry record · Phase 4
Octylseal Surgical Adhesive in General Surgery
A Phase 4 study of Wounds, sponsored by Medline Industries.
- Completed
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
- 2
- Study locations
NCT01514383 is a Phase 4 study of Wounds that has completed, run by Medline Industries. The registered enrollment target is 34 participants, below the 97-participant average among 6 other Wounds trials with a reported enrollment target (65% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01514383, a Phase 4 study of Wounds, has completed, sponsored by Medline Industries.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate how surgical adhesive is used.
Conditions Studied
Interventions
- DEVICE Cyanoacrylate (Octylseal )
Study Locations (2)
New Jersey
- Jersey City Medical Center - Jersey City
New York
- Wyckoff Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01514383
The ClinicalTrials.gov registry entry for NCT01514383 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 97-participant average among 6 other Wounds trials with a reported enrollment target (65% lower). The listed sponsor is Medline Industries, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Wounds appearing as the primary indexed condition, and to 1 intervention - of which Cyanoacrylate (Octylseal ) is the first listed.
NCT01514383 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT01514383 about?
NCT01514383 is a clinical study titled "Octylseal Surgical Adhesive in General Surgery". The purpose of this study is to evaluate how surgical adhesive is used.
What is the current status of trial NCT01514383?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2012-01. Estimated completion is 2012-10.
What conditions does trial NCT01514383 study?
This clinical trial studies the following conditions: Wounds.
What interventions are being tested in trial NCT01514383?
The interventions under investigation include: Cyanoacrylate (Octylseal ) (DEVICE).
Who is sponsoring clinical trial NCT01514383?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01514383 being conducted?
This trial has 2 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wounds
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Tissue Repair Gel in Venous Leg Ulcers (US)
RECRUITING · Phase 3
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Venous Leg Ulcers Using a Non-Bordered Foam Dressing
RECRUITING · NA
-
4-aminopyridine for Skin Wound Healing
RECRUITING · Phase 2
-
Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser Ablation
COMPLETED · Phase 2
-
Platelets in Acute Wounds: A Pilot Study (PAWS)
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.